Carmignac Gestion Adverum Biotechnologies, Inc. Transaction History
Carmignac Gestion
- $5.82 Billion
- Q3 2024
A detailed history of Carmignac Gestion transactions in Adverum Biotechnologies, Inc. stock. As of the latest transaction made, Carmignac Gestion holds 94,600 shares of ADVM stock, worth $403,941. This represents 0.01% of its overall portfolio holdings.
Number of Shares
94,600Holding current value
$403,941% of portfolio
0.01%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding ADVM
# of Institutions
3Shares Held
524KCall Options Held
0Put Options Held
0About Adverum Biotechnologies, Inc.
- Ticker ADVM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 99,333,600
- Market Cap $424M
- Description
- Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...